Clinical Trials on Application in Singapore

Total 2 results

  • Danone Asia Pacific Holdings Pte, Ltd.
    Terminated
    User Experience of a Mobile Application (SMart)
    User Experience of Mobile Application
    Singapore
  • Novartis Pharmaceuticals
    Completed
    A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
    Advanced Solid Tumors With Alterations of FGFR1, 2 and or 3 | Squamous Lung Cancer With FGFR1 Amplification | Bladder Cancer With FGFR3 Mutation or Fusion | Advanced Solid Tumors With FGFR1 Amplication | Advanced Solid Tumors With FGFR2 Amplication | Advanced Solid Tumors With FGFR3 Mutation
    France, Spain, Taiwan, Germany, Netherlands, Singapore, United States, Australia, Korea, Republic of, Thailand, Israel, Italy, Turkey, Austria

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Paraguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe